Background: Lymph node metastasis is one of the most critical prognostic factors in
Introduction
Colorectal cancer is a very common type of cancer worldwide and is now the third leading cause of cancer-related death in Japan [1, 2] . The presence of lymph node metastasis is clearly related to the prognoses of patients, and accurate diagnosis of nodal involvement is essential to planning therapeutic strategies, such as an extent of lymph node dissection and adjuvant chemotherapy [3] [4] [5] [6] . The goal of surgical treatment for colon cancer is the resection of the involved bowel segment and its lymphatic drainage at the level of the primary feeding arterial vessel (e.g., ileocolic, middle colic, left colic, inferior mesenteric artery) [6, 7] . Postoperative pathological examination is currently the gold standard for evaluating regional lymph node metastasis.
Despite improvements in preoperative imaging, such as computed tomography (CT), magnetic resonance tomography (MRI), and fluorodeoxyglucose positron emission tomography (FDG-PET), it is still difficult to accurately assess nodal involvement. Techniques for intraoperative diagnosis of lymph node metastases, including sentinel lymph node biopsy, also remain to be well established [3] . If lymph node metastases were able to be accurately diagnosed at the time of surgical retrieval, the extent of lymph node dissection could be determined in accordance with the nodal status of each patient. Most surgeons believe that appropriate lymphadenectomy can improve short-and long-term outcomes, although evidence supporting the therapeutic significance of lymph node dissection is rather limited [6, 8] .
Fluorescence diagnosis using 5-aminolevulinic acid (5-ALA) is a promising technique that has been used to evaluate various kinds of malignancies in neurosurgery [9, 10] , urology [11, 12] , dermatology [13, 14] , thoracic surgery [15] , gynecology [16] , and gastrointestinal surgery [17] . After exogenous administration of 5-ALA, protoporphyrin IX (PPIX), the last metabolite in heme synthesis, accumulates in malignant cells. Although the mechanism of PPIX accumulation has not been completely defined, several factors concerning 5ALA metabolism, such as reduced 4 activity of ferrochelatase, which converts PPIX to heme, low Fe 2+ levels, and increased NO, are possibly involved rather than 5ALA uptake [18] [19] [20] . PPIX can be detected as red fluorescence when excited by blue light with a wavelength of 405 nm, enabling tumor lesions to be distinguished from normal tissues.
In this study, we evaluated the effectiveness of fluorescence diagnosis, using 5-ALA administered intraperitoneally or orally, for the detection of lymph node metastases from colon cancer in an experimental setting.
Materials and methods
Animals 5-to 8-week-old female KSN nu/nu mice were purchased from Japan SLC (Hamamatsu, Japan). The mice had been raised from birth in a specific pathogen-free environment, and all in vivo experiments were conducted in accordance with the institutional guidelines of Kyoto University Hospital.
Cell line
Wild-type and green fluorescent protein (GFP)-labeled human colon adenocarcinoma cell line, HCA7, was cultured in D-MEM (Wako Pure Chemical Industries, Osaka, Japan) with 10% serum and penicillin/streptomycin and maintained at 37˚C in a humidified incubator with 5% CO 2 in air. HCA7 cell line stably expressing GFP was generated by retroviral transfection with GFP, as described previously [21] .
Tumor model
An orthotopic colon cancer model was prepared by inoculating the cecal wall of the mice with cancer cells. The animals were anesthetized with diethyl ether and then underwent laparotomy via a midline incision. After the cecum was exposed, 1×10 After exploring the abdominal cavity with the D-Light System in both white light and PDD modes, we extirpated the intestine along with the mesentery and 6 examined the mesenteric lymph nodes again in both modes.
Histopathology
After observation, lymph nodes and some other tissues were extracted and soaked in 4% paraformaldehyde for 24 hours. Hematoxylin and eosin (H&E) staining was performed after fixation.
Results

Formation of lymph node metastasis
We treated 23 animals in all, and details of experiments were described in Table 1 .
Three weeks after cancer-cell inoculation, tumors were successfully generated at the injection site in all experiments (Fig. 1a) . We identified metastases in some meso-colonic lymph nodes (Fig. 1b) . Large numbers of small nodules spreading along the mesenteric vessels were found in all 23 mice (Fig. 1a) . These nodules were ascertained to be metastases from cecal tumors on both histopathological examination and GFP fluorescence (Fig. 1c) . In addition, abdominal wall implantations and peritoneal metastases had developed, accompanied by the accumulation of more or less bloody ascitic fluid (Fig. 1a) .
IP group (5-ALA injected intraperitoneally)
Typical PPIX red fluorescence was observed in the skin, gallbladder, and small and large intestines after intraperitoneal injection of 5-ALA (data not shown). In 3 of 10 animals, meso-colonic lymph nodes showed red fluorescence focally and were pathologically confirmed to be metastatic (Fig. 2a, 2b , Table 1 ). In contrast, non-metastatic lymph nodes were fluorescence-negative (Fig. 2a, 2b ). All nodules in the mesentery that were visible under white light showed clear red fluorescence (Fig. 3a , Table 1 ). Primary tumors and abdominal wall implantations also showed red 7 fluorescence (Fig. 3b, 3c ). Moreover, PPIX fluorescence was detected in peritoneal tissues around the stomach, which proved to be metastases to the pancreas (Fig. 3d) .
The intensity of the fluorescence at 3 hours was considerably stronger than that at 6
hours.
PO group (5-ALA given orally)
Red fluorescence in the skin, gallbladder, and small and large intestines was observed after oral administration of 5-ALA, similar to that in the IP group (data not shown).
PPIX fluorescence was not detected in any meso-colonic lymph nodes or mesenteric nodules at either interval (Fig. 4 , Table 1 ). Only faint fluorescence was seen in some parts of primary tumors and abdominal wall implantations (data not shown).
Discussion
Fluorescence diagnosis using 5-ALA has been studied in various fields since Marik et al.
first reported the value of this photosensitizer in 1987 [22] . Neurosurgeons in Europe have already used this technique clinically for the intraoperative detection of malignant gliomas [10, 23] . The European Association of Urology guidelines also recommend photodynamic diagnosis using hexaminolevulinate (HAL), a hexyl ester derivative of 5-ALA, for the detection of bladder carcinomas [24] . Although the mechanisms of PPIX accumulation remain to be fully defined, this phenomenon is thought to be very tumor-specific. To date, few studies have focused on the ability of 5-ALA to detect lymph node metastases from cancers [25] [26] [27] [28] [29] . Thus, we evaluated the usefulness of fluorescence diagnosis using 5-ALA for the detection of lymph node metastases from colon cancers. Our results demonstrated that PPIX fluorescence induced by intraperitoneal administration of 5-ALA, not by oral, allowed metastatic lymph nodes to be accurately diagnosed in this mouse model.
Before conducting in vivo experiments, 5-ALA-mediated PPIX accumulation 8 in HCA7 was confirmed by fluorescence microscopy, using an in vitro method similar to that employed in previous studies (data not shown) [25, 30] . To induce regional lymph node metastases, we orthotopically injected a suspension of the HCA7 cell line.
The metastasis rate of this model was estimated at approximately 25% by earlier experiments. In addition, a substantial number of nodules in the mesentery were formed in all 23 mice within 3 weeks. Histopathological examination confirmed that most of these nodules contained cancer cells and were thus considered metastases from the cecal tumor. Because the nodules were distributed along the mesenteric vessels and appeared to be located between the peritoneum, they were most likely metastatic lymph nodes rather than peritoneal dissemination.
Our results in the IP group showed that 5-ALA-induced PPIX fluorescence was successfully detected in metastatic portions of regional lymph nodes, while no apparent fluorescence was observed in non-metastatic nodes. Actually, the distribution of fluorescence was associated with pathological findings. We detected PPIX fluorescence in meso-colonic nodes in 3 of 10 animals, and these fluorescent nodes were pathologically confirmed to be metastatic. This ratio would be compatible with the metastatic rate of this model. Unfortunately, we had performed pathological examination not for all lymph nodes, so we cannot exactly describe the sensitivity or specificity of this technique. However, mesenteric nodules, which were formed in all animals and detected macroscopically, showed clear red fluorescence. The fluorescence was bright enough to detect tiny tumors, which were hardly visible under white light.
These results suggest the strong ability of intraperitoneal 5ALA to detect cancer tissues.
In addition, primary tumors, abdominal implantations, and pancreatic metastases also showed red fluorescence, suggesting that intraperitoneal 5-ALA might be applied for the intraoperative detection not only of lymph node metastases but also of other occult peritoneal metastases.
Fluorescence at 3 hours was much stronger than that at 6 hours in the IP group. [33] . They found that local administration was superior;
nevertheless, the total dose of 5-ALA was 4-to 5-fold higher than that used for intravenous injection. One hypothesis proposes that intraperitoneally administered 5-ALA is absorbed through the peritoneum and distributed via both the systemic circulation and by direct uptake into peritoneal tissues, resulting in higher 5-ALA concentrations and greater PPIX accumulation in lymph nodes and other intraperitoneal organs as compared with systemic administration [31, 33, 34] .
A recent study demonstrated that intravenous injection of 5-ALA was extremely sensitive for the detection of lymph node metastases from rectal cancers, even though the dose was as high as 250 mg/kg body weight [25] . A study in breast cancer reported that it was rather difficult to detect the fluorescence intraoperatively in metastatic sentinel lymph nodes after oral administration of 30 mg/kg of 5-ALA, although the fluorescence intensity of metastatic lymph nodes was significantly higher than that of non-metastatic lymph nodes [27] . Another study showed that the porphyrin concentrations of cancerous tissues rose dose-dependently after an intravenous dose of up to 300 mg/kg of 5-ALA [37] . These findings suggest that PPIX fluorescence would probably be detected after oral administration of a much higher dose of 5-ALA than that in our model. Many experimental studies have indicated that 5-ALA can be administered in much higher doses without serious side effects [23, 38] . Nonetheless, most clinical studies have used relatively low doses of up to 60 mg/kg body weight [17, 26-28, 34, 39] , and the only approved dose of oral 5-ALA is as little as 20 mg/kg for the detection of gliomas [23, 38] . Increasing the oral dose of 5-ALA thus appears to be impractical for the fluorescence diagnosis of lymph node metastases.
In this small study, we had not fully evaluated the sensitivity and specificity of 5-ALA-induced fluorescence diagnosis of lymph node metastasis. Further precise studies with this animal model which verify the sensitivity and specificity are required to promote clinical translation of this technique.
The penetration depth of red light (630 nm) ranges from 0.2 to 2 cm, and that of exciting blue light (380-440 nm) is even shallower [31] . Moreover, the penetration depth of intraperitoneally administered 5-ALA within lymph nodes is unknown. As discussed previously, these factors might affect the detecting ability in deeper tissue layers [25, 31] . However, the marginal sinus is generally regarded as the initial site of cancer-cell proliferation in regional lymph nodes [40] . Furthermore, PPIX fluorescence induced by intraperitoneal 5-ALA was strong enough to detect, easily and effectively, small metastases within 1-2 mm in diameter in our mouse model. Diagnostic capability for human cancers associated with large lymph nodes, thick layers of endoceliac fat, or both should be evaluated in future.
There is another limitation in translating our technique to clinical use.
Intraperitoneal administration of 5-ALA should be performed under general anesthesia, but it may not be practical to wait for more than 2 hours in the operating room while avoiding exposure to light. Derivatives of 5-ALA, such as HAL, which have better bioavailability than the parent molecule, might solve this problem by shortening the incubation time [41] . Such derivatives are also expected to more potently induce fluorescence in cancers after intraperitoneal administration [42] .
In conclusion, our results demonstrate that fluorescence diagnosis using 
